This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Varshney, A. K.
Right arrow Articles by Malhotra, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Varshney, A. K.
Right arrow Articles by Malhotra, P.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, February 2008, p. 215-220, Vol. 15, No. 2
1071-412X/08/$08.00+0     doi:10.1128/CVI.00283-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Cloning, Expression, and Immunological Characterization of the P30 Protein of Mycoplasma pneumoniae{triangledown}

Avanish Kumar Varshney,1 Rama Chaudhry,1* Sushil Kumar Kabra,2 and Pawan Malhotra3*

Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India,1 Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India,2 International Center for Genetic Engineering and Biotechnology, New Delhi, India3

Received 2 July 2007/ Returned for modification 6 September 2007/ Accepted 7 November 2007

Mycoplasma pneumoniae, a self-replicating cell wall-deficient prokaryote, has a differentiated terminal organelle that is essential for cytadherence and gliding motility. P30, an important protein associated with the terminal organelle, is required for the cytadherence and virulence of M. pneumoniae. P30 is a transmembrane protein with an intracytoplasmic N terminus and an exposed C terminus. In the present study, we amplified and sequenced the full-length p30 gene of Mycoplasma pneumoniae directly from 18 Indian asthmatic patients. Sequence diversity was observed in the p30 genes from 16 clinical samples when the sequences were compared with the sequence of strain M-129. We also successfully expressed a fragment of the p30 gene (P30B) that includes the complete C-terminal proline-rich amino acid sequences in different Escherichia coli expression systems. The maltose binding protein (MBP)-P30B fusion protein was recognized by M. pneumoniae-infected patient sera in immunoblots, and the protein was immunogenic in mice. We further analyzed the reactivity of the MBP-P30B fusion protein with patient sera in an enzyme-linked immunosorbent assay (ELISA) and compared it with the reactivity obtained with a commercial kit (the Serion ELISA Classic kit). The sensitivity and the specificity of the in-house ELISA were 78.57% and 89.47%, respectively. This study suggests that the P30 protein can be used as an antigen along with other adhesin proteins for the immunodiagnosis of M. pneumoniae infection.


* Corresponding author. Mailing address for Rama Chaudhry: Department of Microbiology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India. Phone: 91-11-26594795. Fax: 91-11-26588641. E-mail: ramach003{at}yahoo.com. Mailing address for Pawan Malhotra: Malaria Division, International Center for Genetic Engineering and Biotechnology, Aruna Asaf Ali Marg, New Delhi 110067, India. Phone: 91-11-26195007. Fax: 91-11-26742316. E-mail: pawanm{at}icgeb.res.in

{triangledown} Published ahead of print on 21 November 2007.


Clinical and Vaccine Immunology, February 2008, p. 215-220, Vol. 15, No. 2
1071-412X/08/$08.00+0     doi:10.1128/CVI.00283-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Schurwanz, N., Jacobs, E., Dumke, R. (2009). Strategy To Create Chimeric Proteins Derived from Functional Adhesin Regions of Mycoplasma pneumoniae for Vaccine Development. Infect. Immun. 77: 5007-5015 [Abstract] [Full Text]